Yantai Dongcheng Pharmaceutical Group Co.,Ltd. announced that at the Annual General Meeting of 2022 held on 19 May 2023 approved Cash dividend/10 shares (tax included) of CNY 1.50000000 for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.17 CNY | -2.15% | -6.33% | -28.15% |
05-07 | US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection | MT |
04-29 | Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.15% | 1.5B | |
+22.69% | 43.81B | |
+25.56% | 23.01B | |
+18.26% | 15.27B | |
+9.80% | 13.68B | |
+42.77% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.26% | 5.59B |
- Stock Market
- Equities
- 002675 Stock
- News Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
- Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for 2022